LOKIASV2_3603_ESMFold_hypothetical_protein	2iok-assembly1.cif.gz_B	2iok-assembly1.cif.gz_B Human estrogen receptor alpha ligand-binding domain in complex with compound 1D	3.567E+00	0.179	38	82	144	196	153	216	228	64	0.321	0.281
LOKIASV2_3603_ESMFold_hypothetical_protein	8jta-assembly1.cif.gz_A	8jta-assembly1.cif.gz_A Human VMAT2 complex with tetrabenazine	1.434E+00	0.126	34	1	175	196	203	385	386	198	0.893	0.474
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujy-assembly1.cif.gz_B	7ujy-assembly1.cif.gz_B Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	1.508E+00	0.116	33	4	153	196	73	220	231	157	0.765	0.641
LOKIASV2_3603_ESMFold_hypothetical_protein	7d3u-assembly1.cif.gz_G	7d3u-assembly1.cif.gz_G Structure of Mrp complex from Dietzia sp. DQ12-45-1b	8.435E+00	0.106	32	56	144	196	4	91	111	91	0.454	0.793
LOKIASV2_3603_ESMFold_hypothetical_protein	2i0j-assembly2.cif.gz_D	2i0j-assembly2.cif.gz_D Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia	2.769E+00	0.106	32	8	147	196	72	213	225	146	0.714	0.631
LOKIASV2_3603_ESMFold_hypothetical_protein	3os8-assembly1.cif.gz_C	3os8-assembly1.cif.gz_C Estrogen Receptor	1.587E+00	0.106	32	7	159	196	72	222	234	163	0.781	0.645
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs1-assembly1.cif.gz_B	7rs1-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-21	5.918E+00	0.098	31	85	159	196	141	209	221	75	0.383	0.312
LOKIASV2_3603_ESMFold_hypothetical_protein	6zoq-assembly1.cif.gz_B	6zoq-assembly1.cif.gz_B Oestrogen receptor ligand binding domain in complex with compound 16	1.756E+00	0.090	30	1	149	196	61	213	225	165	0.760	0.680
LOKIASV2_3603_ESMFold_hypothetical_protein	5tnb-assembly1.cif.gz_A	5tnb-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	3.391E+00	0.090	30	8	147	196	80	213	227	146	0.714	0.590
LOKIASV2_3603_ESMFold_hypothetical_protein	5ak2-assembly1.cif.gz_A	5ak2-assembly1.cif.gz_A Oxyphenylpropenoic acids as Oral Selective Estrogen Receptor Down- Regulators.	2.379E+00	0.090	30	7	174	196	72	228	228	174	0.857	0.689
LOKIASV2_3603_ESMFold_hypothetical_protein	1a52-assembly1.cif.gz_B	1a52-assembly1.cif.gz_B ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL	1.847E+00	0.090	30	1	171	196	66	235	240	188	0.872	0.708
LOKIASV2_3603_ESMFold_hypothetical_protein	8dud-assembly1.cif.gz_A-2	8dud-assembly1.cif.gz_A-2 Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(1-propylpyrrolidin-3-yl)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	4.594E+00	0.082	29	4	144	196	72	210	225	148	0.719	0.618
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs9-assembly1.cif.gz_B	7rs9-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-25	6.548E+00	0.082	29	82	159	196	142	214	226	79	0.398	0.323
LOKIASV2_3603_ESMFold_hypothetical_protein	6wok-assembly2.cif.gz_B	6wok-assembly2.cif.gz_B Crystal structure of estrogen receptor alpha in complex with receptor degrader 6	2.379E+00	0.082	29	6	147	196	75	216	230	154	0.724	0.617
LOKIASV2_3603_ESMFold_hypothetical_protein	5tn1-assembly1.cif.gz_A	5tn1-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol derivative, (8S,9S,13S,14S,E)-17-((4-isopropylphenyl)imino)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol	1.296E+00	0.082	29	1	184	196	67	244	245	205	0.939	0.727
LOKIASV2_3603_ESMFold_hypothetical_protein	7zc2-assembly1.cif.gz_A	7zc2-assembly1.cif.gz_A Dipeptide and tripeptide Permease C (DtpC)	2.633E+00	0.082	29	4	163	196	265	447	471	190	0.816	0.389
LOKIASV2_3603_ESMFold_hypothetical_protein	5a43-assembly1.cif.gz_B	5a43-assembly1.cif.gz_B Crystal structure of a dual topology fluoride ion channel.	2.503E+00	0.076	28	33	141	196	3	124	126	133	0.556	0.968
LOKIASV2_3603_ESMFold_hypothetical_protein	7uj7-assembly1.cif.gz_D	7uj7-assembly1.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with RU39411	3.223E+00	0.076	28	4	144	196	69	209	223	153	0.719	0.632
LOKIASV2_3603_ESMFold_hypothetical_protein	8duk-assembly2.cif.gz_D	8duk-assembly2.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(methylamino)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	3.223E+00	0.076	28	7	175	196	69	224	226	175	0.862	0.690
LOKIASV2_3603_ESMFold_hypothetical_protein	3osa-assembly1.cif.gz_C	3osa-assembly1.cif.gz_C Estrogen Receptor	1.847E+00	0.076	28	4	182	196	70	229	230	186	0.913	0.696
LOKIASV2_3603_ESMFold_hypothetical_protein	2r6y-assembly1.cif.gz_A	2r6y-assembly1.cif.gz_A Estrogen receptor alpha ligand-binding domain in complex with a SERM	2.633E+00	0.076	28	6	153	196	73	222	232	161	0.755	0.647
LOKIASV2_3603_ESMFold_hypothetical_protein	2q70-assembly1.cif.gz_A	2q70-assembly1.cif.gz_A Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand	2.503E+00	0.076	28	4	153	196	75	225	235	164	0.765	0.643
LOKIASV2_3603_ESMFold_hypothetical_protein	6vjd-assembly1.cif.gz_B	6vjd-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	3.947E+00	0.076	28	6	163	196	76	230	235	166	0.806	0.660
LOKIASV2_3603_ESMFold_hypothetical_protein	4iw8-assembly1.cif.gz_A	4iw8-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 9a	2.633E+00	0.076	28	1	184	196	66	238	239	198	0.939	0.724
LOKIASV2_3603_ESMFold_hypothetical_protein	3osa-assembly2.cif.gz_B	3osa-assembly2.cif.gz_B Estrogen Receptor	4.152E+00	0.076	28	6	144	196	80	219	239	151	0.709	0.586
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs7-assembly2.cif.gz_D	7rs7-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	2.913E+00	0.076	28	6	149	196	81	224	239	155	0.735	0.603
LOKIASV2_3603_ESMFold_hypothetical_protein	7tx6-assembly1.cif.gz_A	7tx6-assembly1.cif.gz_A Cryo-EM structure of the human reduced folate carrier in complex with methotrexate	3.752E+00	0.076	28	6	171	196	7	176	398	181	0.847	0.427
LOKIASV2_3603_ESMFold_hypothetical_protein	6bx5-assembly1.cif.gz_A	6bx5-assembly1.cif.gz_A The crystal structure of fluoride channel Fluc Ec2 with Monobody S12	5.626E+00	0.069	27	33	141	196	3	124	125	133	0.556	0.976
LOKIASV2_3603_ESMFold_hypothetical_protein	7kka-assembly1.cif.gz_B	7kka-assembly1.cif.gz_B Fluoride channel Fluc-Ec2 mutant S81A with bromide	2.913E+00	0.069	27	33	141	196	3	124	125	138	0.556	0.976
LOKIASV2_3603_ESMFold_hypothetical_protein	7uzh-assembly1.cif.gz_m	7uzh-assembly1.cif.gz_m Rat Kidney V-ATPase with SidK, State 2	5.084E+00	0.069	27	4	143	196	8	149	150	164	0.714	0.947
LOKIASV2_3603_ESMFold_hypothetical_protein	6dfn-assembly2.cif.gz_D	6dfn-assembly2.cif.gz_D Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa	4.152E+00	0.069	27	6	149	196	71	210	221	152	0.735	0.633
LOKIASV2_3603_ESMFold_hypothetical_protein	3osa-assembly2.cif.gz_D	3osa-assembly2.cif.gz_D Estrogen Receptor	3.064E+00	0.069	27	4	159	196	70	213	226	163	0.796	0.637
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujo-assembly2.cif.gz_C	7ujo-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411	3.752E+00	0.069	27	4	173	196	75	233	233	178	0.867	0.682
LOKIASV2_3603_ESMFold_hypothetical_protein	5kra-assembly2.cif.gz_F	5kra-assembly2.cif.gz_F Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE	2.913E+00	0.069	27	1	184	196	66	235	237	199	0.939	0.717
LOKIASV2_3603_ESMFold_hypothetical_protein	7n9o-assembly2.cif.gz_D	7n9o-assembly2.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain in Complex with Aliphatic SERD S-C10(15)	3.064E+00	0.069	27	6	181	196	65	235	237	192	0.898	0.722
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujm-assembly1.cif.gz_B	7ujm-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative That Increases Receptor Resonance Time in the Nucleus of Breast Cancer Cells	4.152E+00	0.069	27	4	175	196	73	236	238	178	0.878	0.689
LOKIASV2_3603_ESMFold_hypothetical_protein	3osa-assembly1.cif.gz_A	3osa-assembly1.cif.gz_A Estrogen Receptor	2.262E+00	0.069	27	6	173	196	80	239	239	180	0.857	0.669
LOKIASV2_3603_ESMFold_hypothetical_protein	6vjd-assembly2.cif.gz_C	6vjd-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	3.947E+00	0.069	27	3	174	196	74	238	239	181	0.878	0.690
LOKIASV2_3603_ESMFold_hypothetical_protein	7yub-assembly1.cif.gz_R	7yub-assembly1.cif.gz_R S1P-bound human SPNS2	5.918E+00	0.069	27	6	171	196	21	179	429	177	0.847	0.371
LOKIASV2_3603_ESMFold_hypothetical_protein	7zha-assembly1.cif.gz_A	7zha-assembly1.cif.gz_A Structure of human OCT3 in complex with inhibitor decynium-22	3.391E+00	0.069	27	6	158	196	307	451	487	162	0.781	0.298
LOKIASV2_3603_ESMFold_hypothetical_protein	2q70-assembly1.cif.gz_B	2q70-assembly1.cif.gz_B Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand	6.548E+00	0.063	26	7	146	196	69	210	211	147	0.714	0.673
LOKIASV2_3603_ESMFold_hypothetical_protein	7rrx-assembly2.cif.gz_D-3	7rrx-assembly2.cif.gz_D-3 Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-19	3.947E+00	0.063	26	6	143	196	71	200	216	148	0.704	0.602
LOKIASV2_3603_ESMFold_hypothetical_protein	8dub-assembly1.cif.gz_B	8dub-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with ((1'-(4-((1-ethylpyrrolidin-3-yl)methyl)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	3.567E+00	0.063	26	1	144	196	56	202	218	162	0.735	0.674
LOKIASV2_3603_ESMFold_hypothetical_protein	5tn9-assembly2.cif.gz_D	5tn9-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	3.567E+00	0.063	26	8	144	196	73	205	219	146	0.699	0.607
LOKIASV2_3603_ESMFold_hypothetical_protein	2bj4-assembly1.cif.gz_B	2bj4-assembly1.cif.gz_B ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST	4.152E+00	0.063	26	1	148	196	67	221	221	164	0.755	0.701
LOKIASV2_3603_ESMFold_hypothetical_protein	7rry-assembly1.cif.gz_B	7rry-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20	4.368E+00	0.063	26	6	144	196	72	210	221	150	0.709	0.629
LOKIASV2_3603_ESMFold_hypothetical_protein	8duk-assembly1.cif.gz_B	8duk-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(methylamino)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	2.262E+00	0.063	26	6	175	196	58	225	226	189	0.867	0.743
LOKIASV2_3603_ESMFold_hypothetical_protein	5dxq-assembly1.cif.gz_A	5dxq-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(1s,5s)-bicyclo[3.3.1]non-9-ylidenemethanediyl]diphenol	2.379E+00	0.063	26	1	184	196	60	226	227	198	0.939	0.736
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs1-assembly2.cif.gz_D	7rs1-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-21	3.391E+00	0.063	26	4	159	196	70	215	227	165	0.796	0.643
LOKIASV2_3603_ESMFold_hypothetical_protein	7rrz-assembly1.cif.gz_B	7rrz-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	3.391E+00	0.063	26	6	148	196	65	216	229	165	0.730	0.664
LOKIASV2_3603_ESMFold_hypothetical_protein	7r62-assembly1.cif.gz_A-2	7r62-assembly1.cif.gz_A-2 Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Desmethyl ICI164,384 Derivative	4.368E+00	0.063	26	4	174	196	73	233	234	180	0.872	0.688
LOKIASV2_3603_ESMFold_hypothetical_protein	5die-assembly1.cif.gz_B	5die-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoro-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-7a-methyl-5-(2,3,5-trifluoro-4-hydroxyphenyl)octahydro-1H-inden-1-ol	3.752E+00	0.063	26	1	184	196	64	234	235	197	0.939	0.728
LOKIASV2_3603_ESMFold_hypothetical_protein	1sj0-assembly1.cif.gz_A-2	1sj0-assembly1.cif.gz_A-2 Human Estrogen Receptor Alpha Ligand-binding Domain in Complex with the Antagonist Ligand 4-D	4.368E+00	0.063	26	8	176	196	79	241	243	178	0.862	0.671
LOKIASV2_3603_ESMFold_hypothetical_protein	8dwi-assembly1.cif.gz_A	8dwi-assembly1.cif.gz_A Molecular Mechanism of Sialic Acid Transport Mediated by Sialin	6.225E+00	0.063	26	6	192	196	28	217	424	213	0.954	0.448
LOKIASV2_3603_ESMFold_hypothetical_protein	4ybq-assembly2.cif.gz_B	4ybq-assembly2.cif.gz_B Rat GLUT5 with Fv in the outward-open form	3.064E+00	0.063	26	2	168	196	47	193	462	176	0.852	0.318
LOKIASV2_3603_ESMFold_hypothetical_protein	6b24-assembly1.cif.gz_A	6b24-assembly1.cif.gz_A Crystal structure of fluoride channel Fluc Ec2 F80Y Mutant	4.368E+00	0.057	25	33	141	196	2	123	124	138	0.556	0.984
LOKIASV2_3603_ESMFold_hypothetical_protein	6wm4-assembly1.cif.gz_2	6wm4-assembly1.cif.gz_2 Human V-ATPase in state 3 with SidK and ADP	3.223E+00	0.057	25	1	139	196	3	146	150	164	0.709	0.960
LOKIASV2_3603_ESMFold_hypothetical_protein	7rry-assembly2.cif.gz_D	7rry-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20	3.947E+00	0.057	25	6	144	196	70	199	209	148	0.709	0.622
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs0-assembly1.cif.gz_B	7rs0-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-18	3.947E+00	0.057	25	6	142	196	70	206	221	150	0.699	0.620
LOKIASV2_3603_ESMFold_hypothetical_protein	5tsb-assembly1.cif.gz_A	5tsb-assembly1.cif.gz_A Crystal structure of the Zrt-/Irt-like protein from Bordetella bronchiseptica with bound Cd2+	5.084E+00	0.057	25	1	139	196	28	176	224	152	0.709	0.665
LOKIASV2_3603_ESMFold_hypothetical_protein	7wnv-assembly2.cif.gz_D	7wnv-assembly2.cif.gz_D Crystal structure of mutant estrogen receptor alpha Y537S in complex with CO9	5.348E+00	0.057	25	4	146	196	78	214	226	156	0.730	0.606
LOKIASV2_3603_ESMFold_hypothetical_protein	2qzo-assembly1.cif.gz_A	2qzo-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with WAY-169916	2.503E+00	0.057	25	1	184	196	66	226	228	196	0.939	0.706
LOKIASV2_3603_ESMFold_hypothetical_protein	5tnb-assembly2.cif.gz_C	5tnb-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	6.888E+00	0.057	25	7	148	196	79	216	229	146	0.724	0.603
LOKIASV2_3603_ESMFold_hypothetical_protein	5aav-assembly1.cif.gz_A	5aav-assembly1.cif.gz_A Optimization of a novel binding motif to to (E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H- pyrido(3,4-b)indol-1-yl)phenyl)acrylic acid (AZD9496), a potent and orally bioavailable selective estrogen receptor downregulator and antagonist	9.333E+00	0.057	25	88	173	196	154	232	232	87	0.439	0.341
LOKIASV2_3603_ESMFold_hypothetical_protein	1r5k-assembly2.cif.gz_C-2	1r5k-assembly2.cif.gz_C-2 Human Estrogen Receptor alpha Ligand-Binding Domain In Complex With GW5638	4.152E+00	0.057	25	6	171	196	76	230	235	178	0.847	0.660
LOKIASV2_3603_ESMFold_hypothetical_protein	8duk-assembly2.cif.gz_C	8duk-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(methylamino)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	2.503E+00	0.057	25	4	175	196	77	236	238	184	0.878	0.672
LOKIASV2_3603_ESMFold_hypothetical_protein	6zor-assembly1.cif.gz_A	6zor-assembly1.cif.gz_A Oestrogen receptor ligand binding domain in complex with compound 28	3.064E+00	0.057	25	6	174	196	83	238	238	184	0.862	0.655
LOKIASV2_3603_ESMFold_hypothetical_protein	5dkg-assembly1.cif.gz_B	5dkg-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a t-butyl-substituted, methyl, triaryl-ethylene derivative 4,4'-[2-(4-tert-butylphenyl)prop-1-ene-1,1-diyl]diphenol	4.368E+00	0.057	25	1	184	196	66	238	240	197	0.939	0.721
LOKIASV2_3603_ESMFold_hypothetical_protein	2qab-assembly1.cif.gz_B	2qab-assembly1.cif.gz_B Crystal Structure of Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with an Ethyl Indazole Compound	3.567E+00	0.057	25	1	184	196	66	243	245	207	0.939	0.727
LOKIASV2_3603_ESMFold_hypothetical_protein	7xq1-assembly1.cif.gz_A	7xq1-assembly1.cif.gz_A Structure of hSLC19A1+2'3'-CDAS	4.833E+00	0.057	25	6	192	196	11	212	400	214	0.954	0.505
LOKIASV2_3603_ESMFold_hypothetical_protein	4u4w-assembly2.cif.gz_B	4u4w-assembly2.cif.gz_B Structure of a nitrate/nitrite antiporter NarK in nitrate-bound occluded state	6.888E+00	0.057	25	4	111	196	35	146	430	120	0.551	0.260
LOKIASV2_3603_ESMFold_hypothetical_protein	5fdr-assembly2.cif.gz_B	5fdr-assembly2.cif.gz_B Mcl-1 complexed with small molecule inhibitor	8.435E+00	0.051	24	2	153	196	1	143	149	163	0.776	0.960
LOKIASV2_3603_ESMFold_hypothetical_protein	5tn9-assembly1.cif.gz_B	5tn9-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	6.548E+00	0.051	24	6	149	196	71	200	211	146	0.735	0.616
LOKIASV2_3603_ESMFold_hypothetical_protein	2bj4-assembly1.cif.gz_A	2bj4-assembly1.cif.gz_A ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST	4.152E+00	0.051	24	1	146	196	61	217	218	171	0.745	0.720
LOKIASV2_3603_ESMFold_hypothetical_protein	8dus-assembly2.cif.gz_F	8dus-assembly2.cif.gz_F Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(ethylamino)ethoxy)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	4.594E+00	0.051	24	6	174	196	70	219	220	175	0.862	0.682
LOKIASV2_3603_ESMFold_hypothetical_protein	2i0j-assembly1.cif.gz_A	2i0j-assembly1.cif.gz_A Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia	7.622E+00	0.051	24	1	146	196	65	220	221	159	0.745	0.706
LOKIASV2_3603_ESMFold_hypothetical_protein	3uuc-assembly1.cif.gz_A	3uuc-assembly1.cif.gz_A Crystal structure of hERa-LBD (wt) in complex with bisphenol-C	8.018E+00	0.051	24	8	151	196	78	215	221	147	0.735	0.624
LOKIASV2_3603_ESMFold_hypothetical_protein	6pfm-assembly1.cif.gz_A	6pfm-assembly1.cif.gz_A Crystal structure of GDC-0927 bound to estrogen receptor alpha	4.152E+00	0.051	24	1	148	196	64	224	224	171	0.755	0.719
LOKIASV2_3603_ESMFold_hypothetical_protein	6pet-assembly2.cif.gz_B	6pet-assembly2.cif.gz_B Crystal structure of 8-hydroxychromene compound 30 bound to estrogen receptor alpha	5.348E+00	0.051	24	6	149	196	74	216	225	156	0.735	0.636
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs8-assembly1.cif.gz_B	7rs8-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-16	4.594E+00	0.051	24	6	143	196	79	211	227	146	0.704	0.586
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujy-assembly2.cif.gz_D	7ujy-assembly2.cif.gz_D Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	7.246E+00	0.051	24	2	153	196	74	221	227	159	0.776	0.652
LOKIASV2_3603_ESMFold_hypothetical_protein	3uuc-assembly2.cif.gz_C	3uuc-assembly2.cif.gz_C Crystal structure of hERa-LBD (wt) in complex with bisphenol-C	5.626E+00	0.051	24	7	149	196	77	222	229	153	0.730	0.638
LOKIASV2_3603_ESMFold_hypothetical_protein	5e15-assembly1.cif.gz_B	5e15-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol	6.225E+00	0.051	24	6	184	196	81	231	233	182	0.913	0.648
LOKIASV2_3603_ESMFold_hypothetical_protein	5dyb-assembly1.cif.gz_B	5dyb-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-(3,4-dihydronaphthalen-2(1H)-ylidenemethanediyl)diphenol	4.368E+00	0.051	24	1	184	196	66	233	234	199	0.939	0.718
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujy-assembly2.cif.gz_C	7ujy-assembly2.cif.gz_C Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	5.084E+00	0.051	24	4	151	196	73	222	234	160	0.755	0.641
LOKIASV2_3603_ESMFold_hypothetical_protein	5krf-assembly1.cif.gz_B	5krf-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Dynamic WAY derivative, 1a	3.223E+00	0.051	24	1	184	196	66	234	236	201	0.939	0.716
LOKIASV2_3603_ESMFold_hypothetical_protein	5kcc-assembly1.cif.gz_A	5kcc-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Oxabicyclic Heptene Sulfonamide (OBHS-N)	5.084E+00	0.051	24	1	184	196	66	236	237	197	0.939	0.722
LOKIASV2_3603_ESMFold_hypothetical_protein	7qvj-assembly1.cif.gz_A	7qvj-assembly1.cif.gz_A ESTROGEN RECEPTOR ALPHA IN COMPLEX WITH COMPOUND 29	9.818E+00	0.051	24	87	174	196	157	238	238	90	0.449	0.345
LOKIASV2_3603_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_A	1gwq-assembly1.cif.gz_A HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE	3.223E+00	0.051	24	6	184	196	80	242	243	195	0.913	0.671
LOKIASV2_3603_ESMFold_hypothetical_protein	6lz0-assembly1.cif.gz_A	6lz0-assembly1.cif.gz_A Cryo-EM structure of human MCT1 in complex with Basigin-2 in the presence of lactate	6.548E+00	0.051	24	3	164	196	189	351	375	180	0.827	0.435
LOKIASV2_3603_ESMFold_hypothetical_protein	3lg7-assembly1.cif.gz_B	3lg7-assembly1.cif.gz_B Crystal structure of HIV epitope-scaffold 4E10_S0_1EZ3A_002_C	6.225E+00	0.045	23	56	147	196	13	119	124	108	0.469	0.863
LOKIASV2_3603_ESMFold_hypothetical_protein	7u8r-assembly1.cif.gz_o	7u8r-assembly1.cif.gz_o Structure of porcine kidney V-ATPase with SidK, Rotary State 3	5.084E+00	0.045	23	1	139	196	3	145	150	160	0.709	0.953
LOKIASV2_3603_ESMFold_hypothetical_protein	5t92-assembly1.cif.gz_B	5t92-assembly1.cif.gz_B ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-{4-[(1R)-2-(4-fluorophenyl)-6-hydroxy-1-methy l-1,2,3,4- tetrahydroisoquinolin-1-yl]phenyl}prop-2-enoic acid	5.348E+00	0.045	23	1	144	196	51	182	183	159	0.735	0.721
LOKIASV2_3603_ESMFold_hypothetical_protein	6cbz-assembly1.cif.gz_B	6cbz-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Estradiol and GRIP Peptide	3.752E+00	0.045	23	1	184	196	57	222	223	203	0.939	0.744
LOKIASV2_3603_ESMFold_hypothetical_protein	2b23-assembly1.cif.gz_A	2b23-assembly1.cif.gz_A Human estrogen receptor alpha ligand-binding domain and a glucocorticoid receptor-interacting protein 1 NR box II peptide	4.368E+00	0.045	23	1	184	196	62	228	229	198	0.939	0.729
LOKIASV2_3603_ESMFold_hypothetical_protein	5egv-assembly1.cif.gz_A	5egv-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex the 3,4-diaryl-furan derivative 3-chloranyl-4-[4-(2-chloranyl-4-oxidanyl-phenyl)furan-3-yl]phenol	5.348E+00	0.045	23	1	184	196	61	228	229	197	0.939	0.734
LOKIASV2_3603_ESMFold_hypothetical_protein	3os8-assembly2.cif.gz_D	3os8-assembly2.cif.gz_D Estrogen Receptor	3.947E+00	0.045	23	7	159	196	72	217	230	166	0.781	0.635
LOKIASV2_3603_ESMFold_hypothetical_protein	6df6-assembly2.cif.gz_D	6df6-assembly2.cif.gz_D Crystal structure of estrogen receptor alpha in complex with receptor degrader 16ab	4.152E+00	0.045	23	6	173	196	64	231	231	191	0.857	0.727
LOKIASV2_3603_ESMFold_hypothetical_protein	5jmm-assembly1.cif.gz_A	5jmm-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with biochanin A	5.084E+00	0.045	23	1	184	196	65	230	231	200	0.939	0.719
LOKIASV2_3603_ESMFold_hypothetical_protein	6owc-assembly1.cif.gz_A	6owc-assembly1.cif.gz_A Mutant estrogen receptor alpha (ERa) Y537S covalently bound to H3B-6545.	5.348E+00	0.045	23	7	182	196	78	231	232	188	0.898	0.664
LOKIASV2_3603_ESMFold_hypothetical_protein	8du8-assembly1.cif.gz_A	8du8-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-((1-propylazetidin-3-yl)oxy)phenyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone	6.225E+00	0.045	23	4	174	196	75	232	233	180	0.872	0.678
LOKIASV2_3603_ESMFold_hypothetical_protein	6zoq-assembly1.cif.gz_A	6zoq-assembly1.cif.gz_A Oestrogen receptor ligand binding domain in complex with compound 16	3.752E+00	0.045	23	8	174	196	83	234	234	178	0.852	0.650
LOKIASV2_3603_ESMFold_hypothetical_protein	7ndo-assembly1.cif.gz_B	7ndo-assembly1.cif.gz_B ER-PRS*(-) (L536S, L372R) in complex with raloxifene	4.152E+00	0.045	23	5	173	196	75	235	237	182	0.862	0.679
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujo-assembly2.cif.gz_D-2	7ujo-assembly2.cif.gz_D-2 Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411	3.752E+00	0.045	23	4	183	196	78	239	240	191	0.918	0.675
LOKIASV2_3603_ESMFold_hypothetical_protein	1qkt-assembly1.cif.gz_A	1qkt-assembly1.cif.gz_A MUTANT ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL	5.084E+00	0.045	23	4	174	196	81	244	248	183	0.872	0.661
LOKIASV2_3603_ESMFold_hypothetical_protein	4ckg-assembly1.cif.gz_B	4ckg-assembly1.cif.gz_B Helical reconstruction of ACAP1(BAR-PH domain) decorated membrane tubules by cryo-electron microscopy	4.152E+00	0.045	23	34	196	196	94	254	362	177	0.832	0.445
LOKIASV2_3603_ESMFold_hypothetical_protein	4zow-assembly1.cif.gz_A	4zow-assembly1.cif.gz_A Crystal structure of E. coli multidrug transporter MdfA in complex with chloramphenicol	9.818E+00	0.045	23	5	141	196	211	361	391	159	0.699	0.386
LOKIASV2_3603_ESMFold_hypothetical_protein	8pnl-assembly1.cif.gz_A	8pnl-assembly1.cif.gz_A Outward-open conformation of a Major Facilitator Superfamily (MFS) transporter MHAS2168, a homologue of Rv1410 from M. tuberculosis, in complex with an alpaca nanobody	8.873E+00	0.045	23	6	171	196	12	172	483	176	0.847	0.333
LOKIASV2_3603_ESMFold_hypothetical_protein	7uzg-assembly1.cif.gz_j	7uzg-assembly1.cif.gz_j Rat Kidney V-ATPase lacking subunit H, with SidK and NCOA7B, State 1	9.818E+00	0.040	22	4	139	196	8	146	150	153	0.694	0.927
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs8-assembly2.cif.gz_D	7rs8-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-16	6.225E+00	0.040	22	6	144	196	74	201	217	147	0.709	0.590
LOKIASV2_3603_ESMFold_hypothetical_protein	7rrz-assembly2.cif.gz_D	7rrz-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	4.368E+00	0.040	22	6	173	196	61	218	218	185	0.857	0.725
LOKIASV2_3603_ESMFold_hypothetical_protein	8dus-assembly1.cif.gz_B	8dus-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(ethylamino)ethoxy)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	5.626E+00	0.040	22	8	174	196	70	219	221	175	0.852	0.679
LOKIASV2_3603_ESMFold_hypothetical_protein	3os9-assembly1.cif.gz_C	3os9-assembly1.cif.gz_C Estrogen Receptor	5.626E+00	0.040	22	6	182	196	72	220	221	188	0.903	0.674
LOKIASV2_3603_ESMFold_hypothetical_protein	5tn9-assembly1.cif.gz_A	5tn9-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	4.152E+00	0.040	22	7	173	196	79	222	222	174	0.852	0.649
LOKIASV2_3603_ESMFold_hypothetical_protein	8dv7-assembly1.cif.gz_B	8dv7-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(1-propylpyrrolidin-3-yl)ethyl)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	5.626E+00	0.040	22	4	174	196	77	220	223	175	0.872	0.646
LOKIASV2_3603_ESMFold_hypothetical_protein	8dv5-assembly1.cif.gz_B	8dv5-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-((1-pentylpyrrolidin-3-yl)methoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	6.548E+00	0.040	22	4	148	196	74	213	225	154	0.740	0.622
LOKIASV2_3603_ESMFold_hypothetical_protein	5dyd-assembly1.cif.gz_A	5dyd-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-(methylsulfanyl)cyclohexylidene]methanediyl}diphenol	9.333E+00	0.040	22	88	184	196	148	224	225	97	0.495	0.342
LOKIASV2_3603_ESMFold_hypothetical_protein	8dui-assembly1.cif.gz_A	8dui-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(dimethylamino)ethoxy)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	8.435E+00	0.040	22	4	147	196	70	212	227	153	0.735	0.630
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujy-assembly1.cif.gz_A	7ujy-assembly1.cif.gz_A Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	6.888E+00	0.040	22	4	153	196	76	222	228	162	0.765	0.645
LOKIASV2_3603_ESMFold_hypothetical_protein	4iv4-assembly1.cif.gz_A	4iv4-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 5b	5.348E+00	0.040	22	1	184	196	62	228	229	197	0.939	0.729
LOKIASV2_3603_ESMFold_hypothetical_protein	5tlo-assembly1.cif.gz_A	5tlo-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with a Squaric Acid-linked Dimeric Estrogen	6.888E+00	0.040	22	1	184	196	63	228	229	194	0.939	0.725
LOKIASV2_3603_ESMFold_hypothetical_protein	5tlo-assembly1.cif.gz_B	5tlo-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with a Squaric Acid-linked Dimeric Estrogen	5.084E+00	0.040	22	1	184	196	65	231	232	202	0.939	0.720
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_A	7ujf-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	8.018E+00	0.040	22	6	147	196	78	215	232	154	0.724	0.595
LOKIASV2_3603_ESMFold_hypothetical_protein	7rrz-assembly1.cif.gz_A	7rrz-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	7.246E+00	0.040	22	6	142	196	80	217	234	151	0.699	0.590
LOKIASV2_3603_ESMFold_hypothetical_protein	4iw6-assembly1.cif.gz_B	4iw6-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 7b	7.622E+00	0.040	22	1	184	196	66	234	235	198	0.939	0.719
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs0-assembly2.cif.gz_C	7rs0-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-18	8.435E+00	0.040	22	6	144	196	81	221	236	152	0.709	0.597
LOKIASV2_3603_ESMFold_hypothetical_protein	4iv2-assembly1.cif.gz_B	4iv2-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 5a	4.152E+00	0.040	22	1	184	196	66	237	238	202	0.939	0.723
LOKIASV2_3603_ESMFold_hypothetical_protein	5tmv-assembly1.cif.gz_B	5tmv-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS analog, 4-iodophenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	4.833E+00	0.040	22	1	184	196	67	238	239	201	0.939	0.720
LOKIASV2_3603_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_B	1gwq-assembly1.cif.gz_B HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE	4.594E+00	0.040	22	6	184	196	79	241	242	193	0.913	0.674
LOKIASV2_3603_ESMFold_hypothetical_protein	7a0g-assembly1.cif.gz_EEE	7a0g-assembly1.cif.gz_EEE Structure of the SmhB pore of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.	3.752E+00	0.040	22	19	188	196	140	310	329	192	0.867	0.520
LOKIASV2_3603_ESMFold_hypothetical_protein	6cjq-assembly1.cif.gz_A	6cjq-assembly1.cif.gz_A Structure of the SthK cyclic nucleotide-gated potassium channel	8.873E+00	0.040	22	43	190	196	98	243	392	153	0.755	0.372
LOKIASV2_3603_ESMFold_hypothetical_protein	4ybq-assembly1.cif.gz_A	4ybq-assembly1.cif.gz_A Rat GLUT5 with Fv in the outward-open form	4.152E+00	0.040	22	1	183	196	6	231	452	246	0.934	0.500
LOKIASV2_3603_ESMFold_hypothetical_protein	7zh6-assembly1.cif.gz_A	7zh6-assembly1.cif.gz_A Structure of human OCT3 in complex with inhibitor Corticosterone	6.888E+00	0.040	22	6	167	196	303	462	478	180	0.827	0.335
LOKIASV2_3603_ESMFold_hypothetical_protein	7udb-assembly1.cif.gz_B	7udb-assembly1.cif.gz_B Cryo-EM structure of a synaptobrevin-Munc18-1-syntaxin-1 complex class 2	8.873E+00	0.034	21	56	182	196	23	175	208	153	0.648	0.736
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujw-assembly2.cif.gz_A	7ujw-assembly2.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Possesses Selective Estrogen Receptor Degrader Activities	7.246E+00	0.034	21	1	144	196	56	198	210	161	0.735	0.681
LOKIASV2_3603_ESMFold_hypothetical_protein	8du9-assembly1.cif.gz_A	8du9-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone	8.018E+00	0.034	21	6	174	196	69	221	221	177	0.862	0.692
LOKIASV2_3603_ESMFold_hypothetical_protein	4iui-assembly1.cif.gz_B	4iui-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY derivative, 4a	9.818E+00	0.034	21	6	184	196	74	219	221	181	0.913	0.661
LOKIASV2_3603_ESMFold_hypothetical_protein	2jfa-assembly1.cif.gz_B	2jfa-assembly1.cif.gz_B ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH AN AFFINITY-SELECTED COREPRESSOR PEPTIDE	9.818E+00	0.034	21	6	146	196	80	221	222	153	0.719	0.640
LOKIASV2_3603_ESMFold_hypothetical_protein	5kcw-assembly1.cif.gz_B	5kcw-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-trifluoroethyl OBHS-N derivative	7.246E+00	0.034	21	1	184	196	67	223	224	198	0.939	0.701
LOKIASV2_3603_ESMFold_hypothetical_protein	8dv5-assembly1.cif.gz_A	8dv5-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-((1-pentylpyrrolidin-3-yl)methoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	8.435E+00	0.034	21	6	147	196	73	213	229	157	0.724	0.616
LOKIASV2_3603_ESMFold_hypothetical_protein	5e0w-assembly1.cif.gz_B	5e0w-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-(4-hydroxyphenyl)cyclohexylidene]methanediyl}diphenol	5.348E+00	0.034	21	1	182	196	63	227	230	203	0.929	0.717
LOKIASV2_3603_ESMFold_hypothetical_protein	5duh-assembly1.cif.gz_B	5duh-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-3 analog phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-3-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide	6.225E+00	0.034	21	1	184	196	64	231	233	197	0.939	0.721
LOKIASV2_3603_ESMFold_hypothetical_protein	2qxm-assembly1.cif.gz_A	2qxm-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Burned Meat Compound PhIP	7.622E+00	0.034	21	3	184	196	76	231	233	190	0.929	0.670
LOKIASV2_3603_ESMFold_hypothetical_protein	6dfn-assembly1.cif.gz_A	6dfn-assembly1.cif.gz_A Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa	9.818E+00	0.034	21	6	146	196	80	219	234	153	0.719	0.598
LOKIASV2_3603_ESMFold_hypothetical_protein	5tll-assembly1.cif.gz_B	5tll-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-2-chloro-4'-hydroxy-4-((hydroxyiminio)methyl)-[1,1'-biphenyl]-3-olate	7.622E+00	0.034	21	1	184	196	65	233	234	197	0.939	0.722
LOKIASV2_3603_ESMFold_hypothetical_protein	1ere-assembly2.cif.gz_C	1ere-assembly2.cif.gz_C HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL	6.225E+00	0.034	21	6	184	196	75	234	235	189	0.913	0.681
LOKIASV2_3603_ESMFold_hypothetical_protein	6vjd-assembly1.cif.gz_A	6vjd-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	6.888E+00	0.034	21	6	174	196	74	234	235	182	0.862	0.685
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs4-assembly2.cif.gz_D	7rs4-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-8	6.225E+00	0.034	21	6	174	196	71	243	243	190	0.862	0.712
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs4-assembly1.cif.gz_A	7rs4-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-8	6.225E+00	0.034	21	6	173	196	74	244	244	190	0.857	0.701
LOKIASV2_3603_ESMFold_hypothetical_protein	4lds-assembly1.cif.gz_B	4lds-assembly1.cif.gz_B The inward-facing structure of the glucose transporter from Staphylococcus epidermidis	6.888E+00	0.034	21	1	184	196	1	210	421	232	0.939	0.499
LOKIASV2_3603_ESMFold_hypothetical_protein	6rw3-assembly2.cif.gz_B	6rw3-assembly2.cif.gz_B The molecular basis for sugar import in malaria parasites.	5.084E+00	0.034	21	6	193	196	9	241	439	249	0.959	0.531
LOKIASV2_3603_ESMFold_hypothetical_protein	8d2w-assembly1.cif.gz_A	8d2w-assembly1.cif.gz_A Zebrafish MFSD2A isoform B in inward open ligand 2B conformation	7.246E+00	0.034	21	1	138	196	229	386	460	179	0.704	0.343
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs3-assembly2.cif.gz_C	7rs3-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-29	9.333E+00	0.029	20	4	143	196	68	197	198	148	0.714	0.657
LOKIASV2_3603_ESMFold_hypothetical_protein	3os9-assembly2.cif.gz_D	3os9-assembly2.cif.gz_D Estrogen Receptor	9.333E+00	0.029	20	6	143	196	70	195	208	147	0.704	0.606
LOKIASV2_3603_ESMFold_hypothetical_protein	2jf9-assembly1.cif.gz_B-2	2jf9-assembly1.cif.gz_B-2 ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST	9.333E+00	0.029	20	1	148	196	58	209	209	165	0.755	0.727
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs0-assembly2.cif.gz_D	7rs0-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-18	8.018E+00	0.029	20	6	142	196	70	195	210	146	0.699	0.600
LOKIASV2_3603_ESMFold_hypothetical_protein	5e15-assembly1.cif.gz_A	5e15-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol	7.246E+00	0.029	20	8	184	196	74	217	218	184	0.903	0.661
LOKIASV2_3603_ESMFold_hypothetical_protein	6wok-assembly1.cif.gz_A	6wok-assembly1.cif.gz_A Crystal structure of estrogen receptor alpha in complex with receptor degrader 6	8.873E+00	0.029	20	4	149	196	71	210	225	158	0.745	0.622
LOKIASV2_3603_ESMFold_hypothetical_protein	5dks-assembly1.cif.gz_B	5dks-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 2-naphthylamino-substituted, ethyl, triaryl-ethylene derivative 4,4'-{2-[3-(naphthalen-1-ylamino)phenyl]but-1-ene-1,1-diyl}diphenol	6.888E+00	0.029	20	1	184	196	64	226	227	198	0.939	0.718
LOKIASV2_3603_ESMFold_hypothetical_protein	2yat-assembly1.cif.gz_A-2	2yat-assembly1.cif.gz_A-2 Crystal structure of estradiol derived metal chelate and estrogen receptor-ligand binding domain complex	6.888E+00	0.029	20	6	182	196	75	224	227	187	0.903	0.661
LOKIASV2_3603_ESMFold_hypothetical_protein	7msa-assembly2.cif.gz_B	7msa-assembly2.cif.gz_B GDC-9545 in complex with estrogen receptor alpha	8.873E+00	0.029	20	6	149	196	75	218	228	161	0.735	0.632
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs7-assembly1.cif.gz_B	7rs7-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	9.333E+00	0.029	20	6	147	196	69	214	228	159	0.724	0.640
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujo-assembly1.cif.gz_A	7ujo-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411	9.818E+00	0.029	20	4	147	196	72	214	231	153	0.735	0.619
LOKIASV2_3603_ESMFold_hypothetical_protein	4tv1-assembly1.cif.gz_B	4tv1-assembly1.cif.gz_B Crystal structure of hERa-LBD (Y537S) in complex with propylparaben	9.333E+00	0.029	20	1	184	196	64	232	233	197	0.939	0.725
LOKIASV2_3603_ESMFold_hypothetical_protein	5dz0-assembly1.cif.gz_B	5dz0-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(4-methylcyclohexylidene)methanediyl]diphenol	4.152E+00	0.029	20	1	182	196	66	230	234	198	0.929	0.705
LOKIASV2_3603_ESMFold_hypothetical_protein	7kbs-assembly1.cif.gz_B	7kbs-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Raloxifene	6.548E+00	0.029	20	4	173	196	77	234	234	182	0.867	0.675
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_B	7ujf-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	8.018E+00	0.029	20	6	175	196	63	233	235	188	0.867	0.728
LOKIASV2_3603_ESMFold_hypothetical_protein	1x7r-assembly1.cif.gz_A-2	1x7r-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN	6.888E+00	0.029	20	7	153	196	72	227	235	167	0.750	0.664
LOKIASV2_3603_ESMFold_hypothetical_protein	5tly-assembly1.cif.gz_B	5tly-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 3,4-bis(2-fluoro-4-hydroxyphenyl)thiophene 1,1-dioxide	6.888E+00	0.029	20	1	184	196	66	235	236	208	0.939	0.720
LOKIASV2_3603_ESMFold_hypothetical_protein	4mg8-assembly1.cif.gz_B	4mg8-assembly1.cif.gz_B Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalanol	6.548E+00	0.029	20	1	184	196	68	235	237	205	0.939	0.709
LOKIASV2_3603_ESMFold_hypothetical_protein	2qgt-assembly1.cif.gz_A	2qgt-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to an Ether Estradiol Compound	5.348E+00	0.029	20	1	184	196	66	236	237	205	0.939	0.722
LOKIASV2_3603_ESMFold_hypothetical_protein	5krc-assembly1.cif.gz_B	5krc-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Zearalenone	8.435E+00	0.029	20	1	184	196	66	235	238	207	0.939	0.714
LOKIASV2_3603_ESMFold_hypothetical_protein	4pps-assembly1.cif.gz_A	4pps-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with an A-CD ring estrogen derivative	8.018E+00	0.029	20	1	184	196	65	237	238	205	0.939	0.727
LOKIASV2_3603_ESMFold_hypothetical_protein	7ujf-assembly2.cif.gz_C	7ujf-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	8.435E+00	0.029	20	3	175	196	74	236	238	184	0.883	0.685
LOKIASV2_3603_ESMFold_hypothetical_protein	5tlt-assembly1.cif.gz_B	5tlt-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with octane-1,8-diyl bis(2,3-bis(4-hydroxyphenyl)pentanoate)	6.225E+00	0.029	20	1	184	196	66	238	240	204	0.939	0.721
LOKIASV2_3603_ESMFold_hypothetical_protein	1pq6-assembly1.cif.gz_B	1pq6-assembly1.cif.gz_B HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX	8.018E+00	0.029	20	4	166	196	90	240	241	175	0.832	0.627
LOKIASV2_3603_ESMFold_hypothetical_protein	1yin-assembly1.cif.gz_A-2	1yin-assembly1.cif.gz_A-2 Human estrogen receptor alpha ligand-binding domain in complex with compound 3F	7.622E+00	0.029	20	9	176	196	66	239	241	192	0.857	0.722
LOKIASV2_3603_ESMFold_hypothetical_protein	6sbo-assembly1.cif.gz_B	6sbo-assembly1.cif.gz_B Estrogen receptor mutant L536S	8.435E+00	0.029	20	6	150	196	80	224	242	157	0.740	0.599
LOKIASV2_3603_ESMFold_hypothetical_protein	2qa6-assembly1.cif.gz_A	2qa6-assembly1.cif.gz_A Crystal Structure of Estrogen Receptor Alpha mutant 537S Complexed with 4-(6-hydroxy-1H-indazol-3-yl)benzene-1,3-diol	5.626E+00	0.029	20	1	184	196	64	241	243	211	0.939	0.733
LOKIASV2_3603_ESMFold_hypothetical_protein	6zos-assembly1.cif.gz_A	6zos-assembly1.cif.gz_A Oestrogen receptor ligand binding domain in complex with compound 18	6.225E+00	0.029	20	1	174	196	68	243	243	196	0.888	0.724
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs4-assembly2.cif.gz_C	7rs4-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-8	7.622E+00	0.029	20	7	173	196	82	244	244	181	0.852	0.668
LOKIASV2_3603_ESMFold_hypothetical_protein	5u2d-assembly1.cif.gz_A	5u2d-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Oxabicyclic Heptene Sulfonate (OBHS)	5.084E+00	0.029	20	1	184	196	66	240	246	209	0.939	0.711
LOKIASV2_3603_ESMFold_hypothetical_protein	7wn1-assembly1.cif.gz_A	7wn1-assembly1.cif.gz_A Structure of PfNT1(Y190A) in complex with nanobody 48 and inosine	5.918E+00	0.029	20	4	136	196	11	176	371	176	0.679	0.447
LOKIASV2_3603_ESMFold_hypothetical_protein	6tz5-assembly1.cif.gz_AA	6tz5-assembly1.cif.gz_AA CryoEM reconstruction of membrane-bound ESCRT-III filament composed of CHMP1B+IST1 (left-handed)	7.622E+00	0.024	19	61	194	196	4	145	175	154	0.684	0.811
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs3-assembly1.cif.gz_A	7rs3-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-29	6.888E+00	0.024	19	4	173	196	68	223	223	182	0.867	0.700
LOKIASV2_3603_ESMFold_hypothetical_protein	1xqc-assembly2.cif.gz_C	1xqc-assembly2.cif.gz_C X-ray structure of ERalpha LBD bound to a tetrahydroisoquinoline SERM ligand at 2.05A resolution	8.018E+00	0.024	19	4	184	196	67	223	224	194	0.923	0.701
LOKIASV2_3603_ESMFold_hypothetical_protein	2qxs-assembly1.cif.gz_B	2qxs-assembly1.cif.gz_B Crystal Structure of Antagonizing Mutant 536S of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Raloxifene	8.435E+00	0.024	19	1	174	196	57	225	226	195	0.888	0.748
LOKIASV2_3603_ESMFold_hypothetical_protein	5u2b-assembly2.cif.gz_D	5u2b-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol, without a coactivator peptide	8.873E+00	0.024	19	7	184	196	72	223	226	188	0.908	0.673
LOKIASV2_3603_ESMFold_hypothetical_protein	5krk-assembly1.cif.gz_A	5krk-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-((5-bromo-2,3-dihydro-1H-inden-1-ylidene)methylene)diphenol	7.622E+00	0.024	19	1	184	196	62	227	228	203	0.939	0.728
LOKIASV2_3603_ESMFold_hypothetical_protein	6suo-assembly1.cif.gz_A	6suo-assembly1.cif.gz_A ERa_L536S (L536S/C381S/C471S,C530S) in complex with a tricyclic indole (compound 6)	8.018E+00	0.024	19	6	174	196	76	228	228	183	0.862	0.671
LOKIASV2_3603_ESMFold_hypothetical_protein	5dp0-assembly1.cif.gz_A	5dp0-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 4-fluorophenylamino-substituted triaryl-ethylene derivative 4,4'-(2-{3-[(4-fluorophenyl)amino]phenyl}ethene-1,1-diyl)diphenol	9.333E+00	0.024	19	1	184	196	63	228	229	201	0.939	0.725
LOKIASV2_3603_ESMFold_hypothetical_protein	2qa8-assembly1.cif.gz_A	2qa8-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with Genistein	5.626E+00	0.024	19	1	184	196	60	229	230	205	0.939	0.739
LOKIASV2_3603_ESMFold_hypothetical_protein	4xi3-assembly1.cif.gz_A	4xi3-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Bazedoxifene	9.333E+00	0.024	19	6	163	196	70	225	230	172	0.806	0.678
LOKIASV2_3603_ESMFold_hypothetical_protein	5dwi-assembly1.cif.gz_A	5dwi-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 2-Chloro-substituted Diaryl-imine analog 4-[(E)-[(2-chlorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol	9.818E+00	0.024	19	1	184	196	64	231	232	199	0.939	0.724
LOKIASV2_3603_ESMFold_hypothetical_protein	6psj-assembly1.cif.gz_A	6psj-assembly1.cif.gz_A Bazedoxifene in Complex with Y537S Estrogen Receptor Alpha Ligand Binding Domain	6.548E+00	0.024	19	3	182	196	67	227	232	191	0.918	0.694
LOKIASV2_3603_ESMFold_hypothetical_protein	5ehj-assembly1.cif.gz_B	5ehj-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(4aR,8aR)-octahydronaphthalen-2(1H)-ylidenemethanediyl]diphenol	6.548E+00	0.024	19	1	184	196	65	233	234	200	0.939	0.722
LOKIASV2_3603_ESMFold_hypothetical_protein	5drm-assembly1.cif.gz_B	5drm-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 2,5-diarylthiophene-core ligand 4,4'-thiene-2,5-diylbis(3-chlorophenol)	9.333E+00	0.024	19	1	184	196	61	234	235	205	0.939	0.740
LOKIASV2_3603_ESMFold_hypothetical_protein	8dus-assembly1.cif.gz_A	8dus-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(ethylamino)ethoxy)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	8.435E+00	0.024	19	6	174	196	78	234	235	181	0.862	0.668
LOKIASV2_3603_ESMFold_hypothetical_protein	5dzh-assembly1.cif.gz_B	5dzh-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol	7.246E+00	0.024	19	1	184	196	66	232	235	200	0.939	0.711
LOKIASV2_3603_ESMFold_hypothetical_protein	5e19-assembly1.cif.gz_B	5e19-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative methyl {4-[bis(4-hydroxyphenyl)methylidene]cyclohexyl}acetate	9.818E+00	0.024	19	1	184	196	66	237	238	199	0.939	0.723
LOKIASV2_3603_ESMFold_hypothetical_protein	4mg7-assembly1.cif.gz_A	4mg7-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with ferutinine	8.018E+00	0.024	19	1	184	196	66	237	239	200	0.939	0.720
LOKIASV2_3603_ESMFold_hypothetical_protein	3hlv-assembly1.cif.gz_A	3hlv-assembly1.cif.gz_A Crystal structure of human Estrogen Receptor Alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide and 16-alpha-hydroxy-estrone ((8S,9R,13S,14R,16R)-3,16-dihydroxy-13-methyl-7,8,9,11,12,14,15, 16-octahydro-6H-cyclopenta[a]phenanthren-17-one	7.622E+00	0.024	19	1	184	196	64	239	240	207	0.939	0.733
LOKIASV2_3603_ESMFold_hypothetical_protein	5kra-assembly1.cif.gz_B	5kra-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE	7.622E+00	0.024	19	1	184	196	66	238	240	201	0.939	0.721
LOKIASV2_3603_ESMFold_hypothetical_protein	4mgb-assembly1.cif.gz_A	4mgb-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with TCBPA	5.918E+00	0.024	19	6	184	196	81	239	240	191	0.913	0.663
LOKIASV2_3603_ESMFold_hypothetical_protein	5t1z-assembly1.cif.gz_A	5t1z-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Ethoxytriphenylethylene and GRIP Peptide	8.873E+00	0.024	19	1	182	196	66	236	240	201	0.929	0.712
LOKIASV2_3603_ESMFold_hypothetical_protein	3l03-assembly1.cif.gz_B	3l03-assembly1.cif.gz_B Crystal Structure of human Estrogen Receptor alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II peptide and Estetrol (Estra-1,3,5(10)-triene-3,15 alpha,16alpha,17beta-tetrol)	8.873E+00	0.024	19	1	183	196	66	239	243	199	0.934	0.716
LOKIASV2_3603_ESMFold_hypothetical_protein	4tuz-assembly1.cif.gz_B	4tuz-assembly1.cif.gz_B Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalenol	8.018E+00	0.024	19	1	184	196	66	242	244	203	0.939	0.725
LOKIASV2_3603_ESMFold_hypothetical_protein	1xp6-assembly1.cif.gz_A	1xp6-assembly1.cif.gz_A HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 16	8.435E+00	0.024	19	9	176	196	66	243	245	195	0.857	0.727
LOKIASV2_3603_ESMFold_hypothetical_protein	6chw-assembly1.cif.gz_A	6chw-assembly1.cif.gz_A Estrogen Receptor Alpha Y537S covalently bound to antagonist H3B-5942.	7.246E+00	0.024	19	6	182	196	80	240	246	194	0.903	0.654
LOKIASV2_3603_ESMFold_hypothetical_protein	7rtf-assembly1.cif.gz_A	7rtf-assembly1.cif.gz_A SthK R120A Closed State	8.873E+00	0.024	19	41	191	196	99	247	395	164	0.770	0.377
LOKIASV2_3603_ESMFold_hypothetical_protein	2iok-assembly1.cif.gz_A	2iok-assembly1.cif.gz_A Human estrogen receptor alpha ligand-binding domain in complex with compound 1D	9.818E+00	0.020	18	4	149	196	71	218	227	161	0.745	0.652
LOKIASV2_3603_ESMFold_hypothetical_protein	5kra-assembly2.cif.gz_E	5kra-assembly2.cif.gz_E Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE	9.333E+00	0.020	18	1	184	196	61	227	228	201	0.939	0.732
LOKIASV2_3603_ESMFold_hypothetical_protein	7sfo-assembly1.cif.gz_B	7sfo-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 3-(((2-chloro-5-phenylthieno[2,3-d]pyrimidin-4-yl)amino)methyl)phenol and GRIP Peptide	9.333E+00	0.020	18	1	183	196	64	228	229	196	0.934	0.721
LOKIASV2_3603_ESMFold_hypothetical_protein	5tlg-assembly1.cif.gz_A	5tlg-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-4,4''-dihydroxy-3'-((hydroxyiminio)methyl)-[1,1':2',1''-terphenyl]-4'-olate	8.873E+00	0.020	18	1	184	196	61	228	229	209	0.939	0.734
LOKIASV2_3603_ESMFold_hypothetical_protein	8duh-assembly1.cif.gz_A	8duh-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-((<i>R</i>)-2-methylpyrrolidin-1-yl)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	7.246E+00	0.020	18	1	163	196	2	226	230	238	0.832	0.978
LOKIASV2_3603_ESMFold_hypothetical_protein	5dxq-assembly1.cif.gz_B	5dxq-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(1s,5s)-bicyclo[3.3.1]non-9-ylidenemethanediyl]diphenol	9.333E+00	0.020	18	1	184	196	67	231	232	208	0.939	0.711
LOKIASV2_3603_ESMFold_hypothetical_protein	4iv4-assembly1.cif.gz_B	4iv4-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 5b	8.018E+00	0.020	18	1	184	196	66	231	232	200	0.939	0.716
LOKIASV2_3603_ESMFold_hypothetical_protein	5dug-assembly1.cif.gz_B	5dug-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-2 analog phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide	9.818E+00	0.020	18	1	184	196	66	233	234	199	0.939	0.718
LOKIASV2_3603_ESMFold_hypothetical_protein	4ivw-assembly3.cif.gz_A	4ivw-assembly3.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 6b	9.818E+00	0.020	18	1	184	196	68	233	234	198	0.939	0.709
LOKIASV2_3603_ESMFold_hypothetical_protein	7rs2-assembly2.cif.gz_D	7rs2-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-23	8.873E+00	0.020	18	6	182	196	73	233	234	196	0.903	0.688
LOKIASV2_3603_ESMFold_hypothetical_protein	6pfm-assembly1.cif.gz_D	6pfm-assembly1.cif.gz_D Crystal structure of GDC-0927 bound to estrogen receptor alpha	9.818E+00	0.020	18	6	181	196	76	233	235	191	0.898	0.672
LOKIASV2_3603_ESMFold_hypothetical_protein	3dt3-assembly1.cif.gz_A	3dt3-assembly1.cif.gz_A Human Estrogen receptor alpha LBD with GW368	8.435E+00	0.020	18	6	175	196	73	233	236	190	0.867	0.682
LOKIASV2_3603_ESMFold_hypothetical_protein	8ev1-assembly1.cif.gz_A	8ev1-assembly1.cif.gz_A Dual Modulators	8.873E+00	0.020	18	1	182	196	65	235	237	204	0.929	0.722
LOKIASV2_3603_ESMFold_hypothetical_protein	5tmt-assembly1.cif.gz_A	5tmt-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-((1,3-dihydro-2H-inden-2-ylidene)methylene)diphenol	8.873E+00	0.020	18	1	184	196	66	236	237	201	0.939	0.722
LOKIASV2_3603_ESMFold_hypothetical_protein	4znv-assembly1.cif.gz_A	4znv-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Methoxy-substituted OBHS derivative	9.818E+00	0.020	18	1	185	196	66	233	237	205	0.944	0.709
LOKIASV2_3603_ESMFold_hypothetical_protein	4dma-assembly1.cif.gz_A	4dma-assembly1.cif.gz_A Crystal structure of ERa LBD in complex with RU100132	9.818E+00	0.020	18	6	184	196	81	236	238	190	0.913	0.655
LOKIASV2_3603_ESMFold_hypothetical_protein	4ivw-assembly3.cif.gz_B	4ivw-assembly3.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 6b	8.018E+00	0.020	18	1	184	196	67	237	238	211	0.939	0.718
LOKIASV2_3603_ESMFold_hypothetical_protein	7a0g-assembly1.cif.gz_JJJ	7a0g-assembly1.cif.gz_JJJ Structure of the SmhB pore of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.	9.818E+00	0.020	18	4	141	196	132	246	320	139	0.704	0.359
LOKIASV2_3603_ESMFold_hypothetical_protein	7oix-assembly1.cif.gz_B	7oix-assembly1.cif.gz_B Structure of thermostable human MFSD2A in complex with thermostable human Sync2	9.333E+00	0.020	18	1	184	196	221	446	451	250	0.939	0.501
LOKIASV2_3603_ESMFold_hypothetical_protein	5kra-assembly1.cif.gz_A	5kra-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE	7.622E+00	0.016	17	1	184	196	6	225	226	248	0.939	0.973
LOKIASV2_3603_ESMFold_hypothetical_protein	5kcf-assembly1.cif.gz_B	5kcf-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, 4-methoxybenzyl OBHS-N derivative	9.818E+00	0.016	17	1	184	196	66	226	227	201	0.939	0.709
LOKIASV2_3603_ESMFold_hypothetical_protein	5wgq-assembly1.cif.gz_B	5wgq-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-BCP1	8.018E+00	0.016	17	1	184	196	5	228	229	251	0.939	0.978
LOKIASV2_3603_ESMFold_hypothetical_protein	5dkb-assembly1.cif.gz_B	5dkb-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-methylphenylamino-substituted ethyl triaryl-ethylene derivative 4,4'-(2-{3-[(3-methylphenyl)amino]phenyl}but-1-ene-1,1-diyl)diphenol	8.018E+00	0.016	17	1	184	196	65	231	232	204	0.939	0.720
LOKIASV2_3603_ESMFold_hypothetical_protein	5dy8-assembly1.cif.gz_B	5dy8-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-ethylcyclohexylidene]methanediyl}diphenol	9.333E+00	0.016	17	6	184	196	84	233	235	186	0.913	0.638
LOKIASV2_3603_ESMFold_hypothetical_protein	4iu7-assembly1.cif.gz_A	4iu7-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 2b	9.818E+00	0.016	17	1	184	196	67	234	235	203	0.939	0.715
LOKIASV2_3603_ESMFold_hypothetical_protein	4zn9-assembly1.cif.gz_B	4zn9-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Oxabicyclic Heptene Sulfonate (OBHS)	6.888E+00	0.016	17	1	185	196	6	229	235	252	0.944	0.953
LOKIASV2_3603_ESMFold_hypothetical_protein	5tlu-assembly1.cif.gz_B	5tlu-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the PEG-linked Dimeric Estrogen, EE2-(eg)6-EE2-amine	9.818E+00	0.016	17	1	184	196	66	236	238	206	0.939	0.718
LOKIASV2_3603_ESMFold_hypothetical_protein	5w9d-assembly1.cif.gz_A	5w9d-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S Mutant in Complex with Endoxifen	8.435E+00	0.016	17	6	175	196	77	240	242	190	0.867	0.678
LOKIASV2_3603_ESMFold_hypothetical_protein	7a0g-assembly1.cif.gz_DDD	7a0g-assembly1.cif.gz_DDD Structure of the SmhB pore of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.	5.626E+00	0.016	17	4	143	196	133	267	318	159	0.714	0.425
LOKIASV2_3603_ESMFold_hypothetical_protein	5kro-assembly1.cif.gz_B	5kro-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Methyl(phenyl)amino-substituted Estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(methyl(phenyl)amino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol	9.818E+00	0.014	16	1	183	196	64	227	228	200	0.934	0.719
LOKIASV2_3603_ESMFold_hypothetical_protein	3l03-assembly1.cif.gz_A	3l03-assembly1.cif.gz_A Crystal Structure of human Estrogen Receptor alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II peptide and Estetrol (Estra-1,3,5(10)-triene-3,15 alpha,16alpha,17beta-tetrol)	8.018E+00	0.014	16	6	184	196	12	235	236	251	0.913	0.949
LOKIASV2_3603_ESMFold_hypothetical_protein	2qgw-assembly1.cif.gz_B	2qgw-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with a Chloro-Indazole Compound	8.435E+00	0.014	16	1	184	196	6	240	242	259	0.939	0.971
LOKIASV2_3603_ESMFold_hypothetical_protein	6ne5-assembly4.cif.gz_D	6ne5-assembly4.cif.gz_D Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors that Demonstrate in vivo Activity in Mouse Xenograft Models of Human Cancer	9.333E+00	0.011	15	4	137	196	8	147	148	150	0.684	0.946
LOKIASV2_3603_ESMFold_hypothetical_protein	7uzh-assembly1.cif.gz_b	7uzh-assembly1.cif.gz_b Rat Kidney V-ATPase with SidK, State 2	7.622E+00	0.011	15	3	144	196	46	181	203	161	0.724	0.670
LOKIASV2_3603_ESMFold_hypothetical_protein	5tm8-assembly1.cif.gz_B	5tm8-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, 7-(4-((1R,4S,6R)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)heptanoic acid	9.333E+00	0.011	15	1	184	196	7	227	228	253	0.939	0.969
